Clinical trials recruiting for Ductal Carcinoma in Situ
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Anastrazole | 1 |
| Breast Radiotherapy | 1 |
| Elacestrant | 1 |
| Exemestane | 1 |
| Letrozole | 1 |
| Preoperative PBI | 1 |
| Stereotactic Body Radiation Therapy | 1 |
| Tamoxifen | 1 |
| Testosterone + Anastrazole | 1 |
| Z-endoxifen | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| California | 2 |
| North Carolina | 2 |
| Pennsylvania | 2 |
| Georgia | 1 |
| Illinois | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| New Jersey | 1 |
| New York | 1 |
| Tennessee | 1 |
| Utah | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
- Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
- Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
- Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
- Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
- Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Related conditions
Trials recruiting for Ductal Carcinoma in Situ often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Ductal Carcinoma in Situ trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.